Stock Market
The U.S. major indexes closed as follows: Dow Jones up 0.18% at 51,267.90; S&P 500 up 0.66% at 7,773.95; NASDAQ up 1.05% at 27,477.31. The broader tape remained constructive, with technology and growth shares leading the advance. Market focus stayed on AI infrastructure, chip supply, and select deal-driven names.
Unusual-move stocks were led by a mix of semiconductors, storage, crypto, and M&A names. SpaceX rose 7.63% to $171.09, Tesla Motors gained 2.20% to $378.73, and NVIDIA advanced 2.12% to $238.90.
On the downside, NEBIUS declined 4.22% to $232.57, while Intel fell 2.63% to $116.19 and Apple edged down 0.24% to $332.89.
Other notable movers included Western Digital up 6.34% at $441.64, Seagate Technology PLC up 4.49% at $887.09, Strategy up 2.76% at $164.43, Cerebras Systems up 9.08% at $181.55, and RXO not shown in the tool data.
Among U.S.-listed Chinese names, Alibaba rose 4.68% to $110.80, Baidu climbed 3.17% to $86.99, and PDD Holdings added 3.34% to $77.90.
Several high-volatility names also stood out, with selective strength in internet, education, and small-cap speculative stocks. Futu Holdings rose 7.37% to $109.70, GDS Holdings climbed 6.24% to $29.29, and Tiger Brokers gained 5.77% to $4.40.
On the weaker side, Datasea fell 19.03% to $0.68, E-home Service declined 16.78% to $1.24, and Xiao I Corp dropped 16.57% to $1.51. The pattern suggests investors continued to favor names tied to AI, storage, and capital-market catalysts.
Other Markets
U.S. 10-year Treasury yield fell by 0.00%, latest at 5.31.
USD/CNH rose 0.0371%, at 6.73; USD/HKD rose 0.0011%, at 7.85.
U.S. Dollar Index rose 0.0098%, at 102.13.
WTI crude futures fell 0.21%, at 89.24 USD/bbl; COMEX gold futures rose 0.26%, at 4,167.60 USD/oz.
Top News
1. Roche licensed Alector’s Parkinson’s therapy in a deal worth up to $1.27 billion. Genentech, Roche’s unit, secured exclusive worldwide rights to develop and commercialize the experimental treatment AL050. The agreement includes a $100 million upfront payment and milestone-linked follow-on payments, giving Alector a major funding boost.
2. C.H. Robinson agreed to buy RXO in a $5.8 billion stock-and-cash transaction. The deal expands C.H. Robinson’s North American truck brokerage footprint and strengthens its last-mile delivery coverage. RXO shareholders are set to receive cash and stock at a premium, while C.H. Robinson expects cost synergies within two years.
3. Schneider Electric struck its largest-ever deal to buy PTC for about $22.6 billion. The French industrial group is deepening its data-center software push as demand for AI infrastructure accelerates. PTC shares jumped sharply after the announcement, reflecting the premium attached to the transaction.
4. Vaxcyte said its pneumococcal vaccine met its main goals in a late-stage study. The company reported positive results in adults aged 50 and older, which sent its shares sharply higher in morning trading. The readout improves the company’s path toward potential regulatory progress.
5. Critical Metals received Greenland approval for the Tanbreez mine plan and closure plan. The government sign-off sets a framework for the project through 2050 and covers extraction rights for multiple rare-earth elements. The project still needs additional operating permits before construction can proceed.
6. Tesla reported better-than-expected deliveries, lifting related market attention. The company’s results helped support sentiment around Elon Musk-linked names and broader EV-adjacent trades. Tesla shares moved higher, while adjacent companies such as SpaceX also drew renewed coverage.
7. Elon Musk said SpaceX is in talks with TSMC regarding the TeraFab project in Texas. The discussion raised questions about how the chip plant may be structured and whether TSMC could supplement Intel’s role. Intel fell as investors weighed the possibility of added competition in the project.
8. Bitcoin-linked profits pushed Strategy back to profitability. The company said it recorded a large unrealized gain on its digital assets, driven by the summer crypto rally. The result revived investor interest in crypto-sensitive stocks and preferred-share financing plans.
9. Morgan Stanley said Nvidia and Broadcom are relatively insulated from the U.S. data-center power crunch. The brokerage argued that power shortages could still delay deployments for some secondary chip suppliers. The note kept attention on infrastructure bottlenecks rather than near-term demand.
10. Bernstein, JPMorgan, and Melius reiterated or upgraded major tech names in fresh calls. Nvidia, Apple, and Microsoft all drew supportive commentary, while Tesla also received reaffirmed bullish coverage. The notes helped extend focus on AI, device demand, and software resilience across large-cap technology.
Sources: Reuters, Dow Jones, Tiger Newspress, public market dataDisclaimer: This content is for reference only and does not constitute investment advice.